|[June 12, 2014]
Research and Markets: Hypoglycemia - Pipeline Review, H1 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/xkdllx/hypoglycemia)
has announced the addition of the "Hypoglycemia
- Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Hypoglycemia, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for
Hypoglycemia and special features on late-stage and discontinued
Drug profiles/records featured in the report undergoesperiodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
The report provides a snapshot of the global therapeutic landscape of
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
The report reviews key players involved in the therapeutics
development for Hypoglycemia and enlists all their major and minor
The report summarizes all the dormant and discontinued pipeline
A review of the Hypoglycemia products under development by companies
and universities/research institutes based on information derived from
company and industry-specific sources
F. Hoffmann-La Roche Ltd.
XERIS Pharmaceuticals, Inc.
Zealand Pharma A/S
For more information visit http://www.researchandmarkets.com/research/xkdllx/hypoglycemia
[ Back To TMCnet.com's Homepage ]